LN-643714
Lesinurad Impurity K , 0.97 , 1533519-96-8
Update time: 2023-04-23
PRODUCT Properties
Boiling point: | 619.8±65.0 °C(Predicted) |
Density | 1.55±0.1 g/cm3(Predicted) |
pka | 2.91±0.10(Predicted) |
Description and Uses
2-[[5-Bromo-4-(4-propyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout.